Disc Medicine (IRON) Non-cash Items (2021 - 2025)
Disc Medicine (IRON) reported Non-cash Items of $137.0 million for Q4 2025, up 28.33% year-over-year from $106.8 million in Q4 2024, and up 28.33% quarter-over-quarter from $106.8 million in Q4 2024.
Disc Medicine (IRON) Non-cash Items (2021 - 2025) Analysis & Trends
Disc Medicine (IRON) has 5 years of Non-cash Items data on file, last reported at $137.0 million in Q4 2025.
- Non-cash Items for Q4 2025 came in at $137.0 million, up 28.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $137.0 million (up 28.33% YoY), and the FY2025 annual result was $137.0 million, up 28.33% from the prior year.
- Non-cash Items rose to $137.0 million in Q4 2025 per IRON's latest filing, from $106.8 million in the prior quarter.
- Over five years, Non-cash Items peaked at $137.0 million in Q4 2025 and troughed at $1.0 million in Q1 2023.
- A 5-year average of $54.3 million and a median of $25.5 million in 2022 frame the typical range for Non-cash Items.
- On a YoY basis, Non-cash Items climbed as much as 11082.64% in 2024 and fell as far as 98.18% in 2024.
- A 5-year view of Non-cash Items shows it stood at $13.0 million in 2021, then surged by 95.85% to $25.5 million in 2022, then soared by 327.54% to $109.1 million in 2023, then decreased by 2.12% to $106.8 million in 2024, then advanced by 28.33% to $137.0 million in 2025.
- Business Quant data shows IRON's Non-cash Items at $137.0 million in Q4 2025, $106.8 million in Q4 2024, and $1.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137.01 Mn |
| Dec 31, 2025 | 137.01 Mn |
| Dec 31, 2024 | 106.77 Mn |
| Dec 31, 2024 | 106.77 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 114.37 Mn |
| Mar 31, 2024 | 114.37 Mn |
| Dec 31, 2023 | 109.08 Mn |
| Dec 31, 2023 | 109.08 Mn |
| Sep 30, 2023 | 86.19 Mn |
| Sep 30, 2023 | 86.19 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 25.51 Mn |
| Dec 31, 2022 | 25.51 Mn |